237 related articles for article (PubMed ID: 15273288)
21. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
22. Analysis of SEMA3B methylation and expression patterns in gastric cancer tissue and cell lines.
Chen R; Zhuge X; Huang Z; Lu D; Ye X; Chen C; Yu J; Lu G
Oncol Rep; 2014 Mar; 31(3):1211-8. PubMed ID: 24402303
[TBL] [Abstract][Full Text] [Related]
23. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
24. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.
Nair PN; McArdle L; Cornell J; Cohn SL; Stallings RL
Cancer Genet Cytogenet; 2007 Apr; 174(2):100-10. PubMed ID: 17452250
[TBL] [Abstract][Full Text] [Related]
25. Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion.
Nasarre P; Kusy S; Constantin B; Castellani V; Drabkin HA; Bagnard D; Roche J
Neoplasia; 2005 Feb; 7(2):180-9. PubMed ID: 15802023
[TBL] [Abstract][Full Text] [Related]
26. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
Guan F; Villegas G; Teichman J; Mundel P; Tufro A
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
[TBL] [Abstract][Full Text] [Related]
27. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.
Guttmann-Raviv N; Shraga-Heled N; Varshavsky A; Guimaraes-Sternberg C; Kessler O; Neufeld G
J Biol Chem; 2007 Sep; 282(36):26294-305. PubMed ID: 17569671
[TBL] [Abstract][Full Text] [Related]
28. Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A.
Narazaki M; Tosato G
Blood; 2006 May; 107(10):3892-901. PubMed ID: 16424390
[TBL] [Abstract][Full Text] [Related]
29. Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading.
Nasarre P; Constantin B; Rouhaud L; Harnois T; Raymond G; Drabkin HA; Bourmeyster N; Roche J
Neoplasia; 2003; 5(1):83-92. PubMed ID: 12659673
[TBL] [Abstract][Full Text] [Related]
30. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines.
Lantuéjoul S; Constantin B; Drabkin H; Brambilla C; Roche J; Brambilla E
J Pathol; 2003 Jul; 200(3):336-47. PubMed ID: 12845630
[TBL] [Abstract][Full Text] [Related]
31. A novel role for vascular endothelial growth factor as an autocrine survival factor for embryonic stem cells during hypoxia.
Brusselmans K; Bono F; Collen D; Herbert JM; Carmeliet P; Dewerchin M
J Biol Chem; 2005 Feb; 280(5):3493-9. PubMed ID: 15572379
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
33. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Weigand M; Hantel P; Kreienberg R; Waltenberger J
Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
[TBL] [Abstract][Full Text] [Related]
34. Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer.
Ochiumi T; Kitadai Y; Tanaka S; Akagi M; Yoshihara M; Chayama K
Int J Oncol; 2006 Jul; 29(1):105-16. PubMed ID: 16773190
[TBL] [Abstract][Full Text] [Related]
35. Functional relevance of the switch of VEGF receptors/co-receptors during peritoneal dialysis-induced mesothelial to mesenchymal transition.
Pérez-Lozano ML; Sandoval P; Rynne-Vidal A; Aguilera A; Jiménez-Heffernan JA; Albar-Vizcaíno P; Majano PL; Sánchez-Tomero JA; Selgas R; López-Cabrera M
PLoS One; 2013; 8(4):e60776. PubMed ID: 23585849
[TBL] [Abstract][Full Text] [Related]
36. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.
Gaur P; Bielenberg DR; Samuel S; Bose D; Zhou Y; Gray MJ; Dallas NA; Fan F; Xia L; Lu J; Ellis LM
Clin Cancer Res; 2009 Nov; 15(22):6763-70. PubMed ID: 19887479
[TBL] [Abstract][Full Text] [Related]
37. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line.
Tse C; Xiang RH; Bracht T; Naylor SL
Cancer Res; 2002 Jan; 62(2):542-6. PubMed ID: 11809707
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin Changes Expression of SEMA3B in Endometrial Cancer.
Peszek W; Kras P; Grabarek BO; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2020; 21(13):1368-1376. PubMed ID: 32410560
[TBL] [Abstract][Full Text] [Related]
39. A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells.
Barr MP; Byrne AM; Duffy AM; Condron CM; Devocelle M; Harriott P; Bouchier-Hayes DJ; Harmey JH
Br J Cancer; 2005 Jan; 92(2):328-33. PubMed ID: 15655556
[TBL] [Abstract][Full Text] [Related]
40. The role of the plexin-A2 receptor in Sema3A and Sema3B signal transduction.
Sabag AD; Smolkin T; Mumblat Y; Ueffing M; Kessler O; Gloeckner CJ; Neufeld G
J Cell Sci; 2014 Dec; 127(Pt 24):5240-52. PubMed ID: 25335892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
